These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21166769)

  • 1. In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells.
    Roubelakis MG; Bitsika V; Zagoura D; Trohatou O; Pappa KI; Makridakis M; Antsaklis A; Vlahou A; Anagnou NP
    J Cell Mol Med; 2011 Sep; 15(9):1896-913. PubMed ID: 21166769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells.
    Moraes DA; Sibov TT; Pavon LF; Alvim PQ; Bonadio RS; Da Silva JR; Pic-Taylor A; Toledo OA; Marti LC; Azevedo RB; Oliveira DM
    Stem Cell Res Ther; 2016 Jul; 7(1):97. PubMed ID: 27465541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentosan polysulfate binds to STRO-1
    Wu J; Shimmon S; Paton S; Daly C; Goldschlager T; Gronthos S; Zannettino ACW; Ghosh P
    Stem Cell Res Ther; 2017 Dec; 8(1):278. PubMed ID: 29237492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer.
    Bitsika V; Roubelakis MG; Zagoura D; Trohatou O; Makridakis M; Pappa KI; Marini FC; Vlahou A; Anagnou NP
    Stem Cells Dev; 2012 May; 21(7):1097-111. PubMed ID: 21988169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AF-MSCs fate can be regulated by culture conditions.
    Zagoura DS; Trohatou O; Bitsika V; Makridakis M; Pappa KI; Vlahou A; Roubelakis MG; Anagnou NP
    Cell Death Dis; 2013 Apr; 4(4):e571. PubMed ID: 23559005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the expression of pluripotency-related genes in human amniotic fluid cells: A semi-quantitative comparison between different subpopulations, from primary to cultured amniocytes.
    Hoseini SM; Montazeri F; Bahrami AR; Kalantar SM; Rahmani S; Zarein F; Matin MM
    Reprod Biol; 2020 Sep; 20(3):338-347. PubMed ID: 32518050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells.
    Roubelakis MG; Pappa KI; Bitsika V; Zagoura D; Vlahou A; Papadaki HA; Antsaklis A; Anagnou NP
    Stem Cells Dev; 2007 Dec; 16(6):931-52. PubMed ID: 18047393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application.
    Sessarego N; Parodi A; Podestà M; Benvenuto F; Mogni M; Raviolo V; Lituania M; Kunkl A; Ferlazzo G; Bricarelli FD; Uccelli A; Frassoni F
    Haematologica; 2008 Mar; 93(3):339-46. PubMed ID: 18268281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sox2 suppression by miR-21 governs human mesenchymal stem cell properties.
    Trohatou O; Zagoura D; Bitsika V; Pappa KI; Antsaklis A; Anagnou NP; Roubelakis MG
    Stem Cells Transl Med; 2014 Jan; 3(1):54-68. PubMed ID: 24307698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization.
    Roubelakis MG; Tsaknakis G; Pappa KI; Anagnou NP; Watt SM
    PLoS One; 2013; 8(1):e54747. PubMed ID: 23359810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human palatine tonsil: a new potential tissue source of multipotent mesenchymal progenitor cells.
    Janjanin S; Djouad F; Shanti RM; Baksh D; Gollapudi K; Prgomet D; Rackwitz L; Joshi AS; Tuan RS
    Arthritis Res Ther; 2008; 10(4):R83. PubMed ID: 18662393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive effect of bFGF and selenium on expansion and paracrine action of human amniotic fluid-derived mesenchymal stem cells.
    Park J; Lee JH; Yoon BS; Jun EK; Lee G; Kim IY; You S
    Stem Cell Res Ther; 2018 Nov; 9(1):293. PubMed ID: 30409167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the neural differentiation potential of human mesenchymal stem cells from amniotic fluid and adult bone marrow.
    Yan ZJ; Hu YQ; Zhang HT; Zhang P; Xiao ZY; Sun XL; Cai YQ; Hu CC; Xu RX
    Cell Mol Neurobiol; 2013 May; 33(4):465-75. PubMed ID: 23478940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial membrane-derived mesenchymal progenitor cells from osteoarthritic joints in dogs possess lower chondrogenic-, and higher osteogenic capacity compared to normal joints.
    Teunissen M; Ahrens NS; Snel L; Narcisi R; Kamali SA; van Osch GJVM; Meij BP; Mastbergen SC; Sivasubramaniyan K; Tryfonidou MA
    Stem Cell Res Ther; 2022 Sep; 13(1):457. PubMed ID: 36064441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term cultivation of human amniotic fluid stem cells: The impact on proliferative capacity and differentiation potential.
    Gasiūnienė M; Valatkaitė E; Navakauskienė R
    J Cell Biochem; 2020 Jul; 121(7):3491-3501. PubMed ID: 31898359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilineage potential research of bovine amniotic fluid mesenchymal stem cells.
    Gao Y; Zhu Z; Zhao Y; Hua J; Ma Y; Guan W
    Int J Mol Sci; 2014 Feb; 15(3):3698-710. PubMed ID: 24590129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and in vitro characterization of bovine amniotic fluid derived stem cells at different trimesters of pregnancy.
    Rossi B; Merlo B; Colleoni S; Iacono E; Tazzari PL; Ricci F; Lazzari G; Galli C
    Stem Cell Rev Rep; 2014 Oct; 10(5):712-24. PubMed ID: 24906426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/ß-catenin-mediated p53 suppression is indispensable for osteogenesis of mesenchymal progenitor cells.
    Zhou X; Beilter A; Xu Z; Gao R; Xiong S; Paulucci-Holthauzen A; Lozano G; de Crombrugghe B; Gorlick R
    Cell Death Dis; 2021 May; 12(6):521. PubMed ID: 34021120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of canine mesenchymal stem cells from amniotic fluid and differentiation into hepatocyte-like cells.
    Choi SA; Choi HS; Kim KJ; Lee DS; Lee JH; Park JY; Kim EY; Li X; Oh HY; Lee DS; Kim MK
    In Vitro Cell Dev Biol Anim; 2013 Jan; 49(1):42-51. PubMed ID: 23242927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels.
    Mareschi K; Rustichelli D; Comunanza V; De Fazio R; Cravero C; Morterra G; Martinoglio B; Medico E; Carbone E; Benedetto C; Fagioli F
    Cytotherapy; 2009; 11(5):534-47. PubMed ID: 19548144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.